Latus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosedMV
Modi Ventures
Activity from announced rounds
Activity in this selectionAI
- Rounds participated in
- 4
- Confirmed lead rounds
- — 4 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $383.8M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionEridu
Develops purpose-built networking silicon and systems for AI data centers and hyperscalers
$200MSeries A
Role not disclosedBrainomix
Develops AI-powered imaging tools for stroke and lung fibrosis
$6.8MSeries C+
Role not disclosedProxima
Develops AI-driven drug discovery for proximity therapeutics
$80MUndisclosed
Role not disclosed